Literature DB >> 25601119

[Resistant human fasciolasis: report of four patients].

Luis Carlos Gil, Alex Díaz, Carlos Rueda, Christian Martínez, Douglas Castillo, Werner Apt.   

Abstract

Human fascioliasis is a parasitic zoonosis that affects the liver of human and herbivorous animals. In chronic cases, its diagnosis is confirmed by direct visualization of parasitic eggs in stool examination, by positive testing for Fasciola hepatica antigens in stools, or by direct observation of parasites by endoscopic retrograde cholangiography or surgery. In acute cases, serological reactions as immunoblothing or detection of parasite antigens in the blood are useful. The treatment of choice is triclabendazole. However, parasite resistance in animals, as well as in man, has been reported to this drug. We report four patients in whom the parasitic infection persisted despite a course of treatment with triclabendazole.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25601119     DOI: 10.4067/S0034-98872014001000014

Source DB:  PubMed          Journal:  Rev Med Chil        ISSN: 0034-9887            Impact factor:   0.553


  10 in total

1.  Fasciola hepatica calcium-binding protein FhCaBP2: structure of the dynein light chain-like domain.

Authors:  Thanh H Nguyen; Charlotte M Thomas; David J Timson; Mark J van Raaij
Journal:  Parasitol Res       Date:  2016-04-16       Impact factor: 2.289

2.  Genomes of Fasciola hepatica from the Americas Reveal Colonization with Neorickettsia Endobacteria Related to the Agents of Potomac Horse and Human Sennetsu Fevers.

Authors:  Samantha N McNulty; Jose F Tort; Gabriel Rinaldi; Kerstin Fischer; Bruce A Rosa; Pablo Smircich; Santiago Fontenla; Young-Jun Choi; Rahul Tyagi; Kymberlie Hallsworth-Pepin; Victoria H Mann; Lakshmi Kammili; Patricia S Latham; Nicolas Dell'Oca; Fernanda Dominguez; Carlos Carmona; Peter U Fischer; Paul J Brindley; Makedonka Mitreva
Journal:  PLoS Genet       Date:  2017-01-06       Impact factor: 5.917

3.  Pleiotropic alterations in gene expression in Latin American Fasciola hepatica isolates with different susceptibility to drugs.

Authors:  Santiago Radio; Santiago Fontenla; Victoria Solana; Anna C Matos Salim; Flávio Marcos Gomes Araújo; Pedro Ortiz; Cristian Hoban; Estefan Miranda; Valeria Gayo; Fabiano Sviatopolk-Mirsky Pais; Hugo Solana; Guilherme Oliveira; Pablo Smircich; José F Tort
Journal:  Parasit Vectors       Date:  2018-01-24       Impact factor: 3.876

4.  Human Cases of Fascioliasis in Fujian Province, China.

Authors:  Lin Ai; Yu-Chun Cai; Yan Lu; Jia-Xu Chen; Shao-Hong Chen
Journal:  Korean J Parasitol       Date:  2017-02-28       Impact factor: 1.341

5.  Evaluation of nitazoxanide treatment following triclabendazole failure in an outbreak of human fascioliasis in Upper Egypt.

Authors:  Haidi Karam-Allah Ramadan; Waleed Attia Hassan; Nahed Ahmed Elossily; Alzahraa Abdelraouf Ahmad; Adnan Ahmed Mohamed; Alaa Soliman Abd-Elkader; Eman M Nagiub Abdelsalam; Hani M J Khojah
Journal:  PLoS Negl Trop Dis       Date:  2019-09-25

6.  Triclabendazole in the treatment of human fascioliasis: a review.

Authors:  Preetam Gandhi; Esther K Schmitt; Chien-Wei Chen; Sanjay Samantray; Vinay Kumar Venishetty; David Hughes
Journal:  Trans R Soc Trop Med Hyg       Date:  2019-12-01       Impact factor: 2.184

Review 7.  Human Fascioliasis: Current Epidemiological Status and Strategies for Diagnosis, Treatment, and Control.

Authors:  Maria Alejandra Caravedo; Miguel Mauricio Cabada
Journal:  Res Rep Trop Med       Date:  2020-11-26

8.  Treatment failure after multiple courses of triclabendazole in a Portuguese patient with fascioliasis.

Authors:  Elsa Alves Branco; Rogerio Ruas; João Nuak; António Sarmento
Journal:  BMJ Case Rep       Date:  2020-03-18

9.  Treatment Failure after Multiple Courses of Triclabendazole among Patients with Fascioliasis in Cusco, Peru: A Case Series.

Authors:  Miguel M Cabada; Martha Lopez; Maria Cruz; Jennifer R Delgado; Virginia Hill; A Clinton White
Journal:  PLoS Negl Trop Dis       Date:  2016-01-25

Review 10.  Drug resistance in liver flukes.

Authors:  I Fairweather; G P Brennan; R E B Hanna; M W Robinson; P J Skuce
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2020-01-10       Impact factor: 4.077

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.